Biotech Market Updates 2 articles

Biotech Market Updates provides a sector-level view of how biotechnology equities and capital markets respond to scientific, clinical, regulatory and financing developments. Index moves, risk appetite, valuation trends and market reactions are useful when they reveal conditions affecting biotech companies broadly. The section avoids generic market commentary: coverage must connect price behavior or capital availability to biotechnology-specific evidence, catalysts or funding dynamics.

Biotech Companies & Pipelines

October 1, 2026, 9:45 AM · 3 mins read

HBM Healthcare Investments forecasts sharp profit jump as private biotech deals pay off

HBM Healthcare Investments expects a half-year profit of CHF 177 million, fueled by big gains in private biotech holdings and major exits, even as listed assets remain volatile.

Biotech Companies & Pipelines

October 1, 2026, 7:08 AM · 3 mins read

Tresalis takes majority control of Vyrao in strategic beauty sector move

Tresalis has stepped into beauty and wellness with its first big move: buying a majority stake in Vyrao, a well-being fragrance brand. The brand keeps its leadership and identity.